sightsciences.com - SGHT Profit before deduction of interest, taxes, depreciation and amortization
Ophthalmologists' reliance on comprehensive solutions from Sight Sciences, Inc. (SGHT) creates concentration risks, yet the Adjusted EBITDA with a metric value of 0.00 confirms financial stability. This stability is further bolstered by stringent FDA requirements and patents for Omni systems, as well as the implementation of robotic microcatheter assembly lines that guarantee precision product quality.
Summary analytical data breakdowns for Sight Sciences (SGHT)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Sight Sciences, Inc.|SGHT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Sight Sciences Inc.|SGHT - Company Aggregate Debts|Debts to Book Value Sight Sciences, Inc.|SGHT - Company Long-Term Debts|Company Short-Term Indebtedness Sight Sciences, Inc.|Interim Coverage Ratio sightsciences.com
- earnings and market multiples details:
SGHT - Net Profit|Future Profit Sight Sciences, Inc.|SGHT - P/E Multiple|Forward P/E Multiple sightsciences.com|SGHT - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sight Sciences, Inc.|SGHT - Operating profit before deduction of amortization|Earnings per share for the trailing year Sight Sciences, Inc.|SGHT - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months sightsciences.com|SGHT - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Sight Sciences, Inc.
Summary company analytics:Sight Sciences, Inc.
Absolute operating profit determines the net liquidity inflow from core operations, reflecting the efficiency of business process monetization under current monetary policy. By analyzing the EBITDA metric, investors assess the ability of Sight Sciences, Inc. (SGHT) to generate cash flow, which is supported by the company's strong pricing power due to the uniqueness of the Omni systems and the inelastic demand for ophthalmological care.
Who Sight Sciences, Inc. competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|TMDX (TransMedics Group, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec ATEC|AORT - Operating profit before deduction of amortization|DJO Global - Operating profit EBITDA|Profit before interest, taxes and amortization Integra LifeSciences Inc.|ESTA: Operating profit EBITDA|Operating profit before amortization BBNX|IRMD (IRADIMED) - Operating profit EBITDA|Embecta Corp (EMBC) - Operating income before deduction of amortization|Operating profit EBITDA TNDM|Operating profit before deduction of amortization Axogen Surgical AXGN|Operating profit EBITDA SIBN (SI-BONE, Inc.)|Operating profit EBITDA orthofix.com OFIX|BVS - Profit before payment of interest, taxes and amortization|KIDS: Profit before payment of interest, taxes and amortization|TMCI (Treace Medical) - Operating profit before deduction of amortization|Strata Medical - Income before deduction of interest, taxes and amortization|CARL (Carlsmed Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization rxsight.com RXST|Profit before payment of interest, taxes and amortization ClearPoint Neuro, Inc. (CLPT)|Stereotaxis Inc (STXS) - Operating profit before depreciation charges|NeuroStar - Operating profit before deduction of amortization|Operating profit EBITDA orchestrabiomed.com OBIO|Anika - Operating profit EBITDA|Operating income before deduction of amortization inspiremd.com NSPR|zhjmedical.com (ZJYL) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VANI (Vivani Medical)|Profit before payment of interest, taxes and amortization Xtant Medical Holdings, Inc.|Operating profit before deduction of amortization NeuroOne Medical Technologies Corp. (NMTC)|Operating profit EBITDA MODD|MYO - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Envoy Medical COCH|VVOS: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies - Company profit before taxes, interest and amortization|Tenon Medical, Inc. (TNON) - Profit before payment of interest, taxes and amortization|LFWD - Operating income before deduction of amortization|AMIX (Autonomix Medical Inc.) - Operating profit EBITDA|INVO Bioscience (IVF) - Operating income before deduction of amortization|Operating profit EBITDA BBLG|Axonics, Inc (AXNX) - Operating profit before depreciation charges|Operating profit EBITDA BIOL (BIOLASE, Inc.)|Income before deduction of interest, taxes and amortization DYNT|FNA: Operating profit before deduction of amortization|INVO Bioscience, Inc. - Company profit before taxes, interest and amortization
